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عملية استئصال ورم الرحم العضلي أثناء إجراء العملية 
القيصرية: إمكانية إجراء العملية والسالمة
لوفينا مات�سادو، فيدياناثان غوري، نهال الريامي، ملياء اخلرو�سي،
ب�سبب املخاوف من حدوث  القي�رضية  العملية  اإجراء  اأثناء  الع�سلي  الرحم  ا�ستئ�سال ورم  تقبل  العادة على عدم  الهدف: جرت  امللخ�ص: 
نزيف قد ي�سعب ال�سيطرة عليه اأثناء العملية اجلراحية وب�سبب امل�ساعفات املتوقعة بعد العملية. ومع ذلك، فقد ظهر موؤخرا يف العديد من 
االأبحاث اأن ا�ستئ�سال ورم الرحم الع�سلي اأثناء العملية القي�رضية اليزيد من خطر النزف اأو امل�ساعفات بعد العملية اجلراحية.  الطريقة: 
نقدم هنا و�سفا لثمان حاالت من م�ست�سفى جامعة ال�سلطان قابو�س، ُعمان، حيث مت اإجراء ا�ستئ�سال اأورام ليفية يف اأ�سفل الرحم اأثناء 
والتي مت  للرحم  اخللفي  اجلدار  ليفي يف  االأمامي، وورم  الرحم  امل�ستاأ�سلة يف جدار  الليفية  االأورام  �سبعة من  القي�رضية. كانت  العملية 
ا�ستئ�ساله  للتمكن من اإغالق �سق الرحم. النتائج:  كان متو�سط عمر الن�ساء الالتي مت اإجراء العملية لهن 28.7 �سنة ومتو�سط عمر احلمل 
عند الوالدة 36.75 اأ�سبوعا. و فيما يتعلق بفقدان الدم اأثناء العملية، فقدت مري�سة واحدة 900 مل، وخم�س ن�ساء فقدن بني 1 – 1.5 
لرتا، واثنتان فقدن بني 1.5 - 2 لرتا، وفقدت امراأة 3.2 لرتا من الدم حيث كان قيا�س الورم الليفي عندها 10×12 �سم. وعلى الرغم من 
كون اأغلبية االأورام الليفية  كبرية )7 من االأورام الليفية كانت اأكرب من 5 �سم يف احلجم( و ٪50 منها �سنفت من �سمن التليفات الداخلة 
يف اجلدار الع�سلي للرحم، مل تكن هناك حاجة ال�ستئ�سال الرحم. وقد ا�ستدعت حالة واحدة لقطع التغذية الدموية، بينما ا�ستدعت حالة 
اأخرى  للق�سطرة ببالون �رضيان الرحم قبل اإجراء العملية. مت التاأكد من حجم االأورام الليفية عن طريق فح�س الن�سيج املر�سي بعد عملية 
اال�ستئ�سال. عملية ا�سئ�سال الورم الليفي اأ�سافت 15 دقيقة اإىل الوقت الكلي املعتاد الإجراء العملية القي�رضية ويوما واحدا اآخرا للبقاء 
يف امل�ست�سفى ومل ت�سجل اأية م�ساعفات لالأمهات اأو اأطفالهن خالل املكوث يف امل�ست�سفى. اخلال�صة: ا�ستئ�سال اأورام الرحم الع�سلية اأثناء 
العملية القي�رضية يف ن�ساء خمتارات هو اإجراء اآمن وفّعال يف م�ست�سفيات الرعاية الثالثية  بوجود جراحني ذوي خربة.
مفتاح الكلمات: والدة قي�رضية، عملية ا�ستئ�سال ورم الرحم الع�سلي، اأورام ليفية، حمل، نزيف، ُعمان.
abstract: Objectives: Caesarean myomectomy has traditionally been discouraged due to fears of intractable 
haemorrhage and increased postoperative morbidity. However, a number of authors have recently shown that 
myomectomy during Caesarean section does not increase the risk of haemorrhage or postoperative morbidity. 
Methods: We present a series of 8 cases from Sultan Qaboos University Hospital, Oman, where myomectomy was 
performed during Caesarean section for large lower segment fibroids. Seven were anterior lower segment fibroids, 
while one was a posterior lower uterine fibroid which interfered with closure of the uterine incision. The antenatal 
course, perioperative management, and postoperative morbidity are discussed. Results: The average age of the 
women was 28.7 years and mean gestational age at delivery was 36.75 weeks. Regarding intra-operative blood loss, 
1 patient lost 900 ml, 5 patients lost 1–1.5 litres, 2 lost 1.5–2 L, and 1 patient with a 10 x 12 cm fibroid lost 3.2 L. 
Despite the majority being large myomas (7 of the 8 patients had myomas >5 cm in size) and 50% being intramural, 
no hysterectomy was required. Stepwise devascularisation was necessary in one case and preoperative placement 
of uterine balloon catheters was necessary in another. The size of the fibroids was confirmed by histopathology. 
Myomectomy added 15 minutes to the operating time and 1 day to the hospital stay, but there was no significant 
postoperative morbidity. Neonatal outcome was good in all patients. Conclusion: In selected patients, myomectomy 
during Caesarean section is a safe and effective procedure at tertiary centres with experienced surgeons.
Keywords: Caesarean section; Myomectomy; Fibroids; Pregnancy; Haemorrhage; Oman.
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Advances in knowledge 
- This is the first study in Oman addressing the controversial and important issue of performing myomectomy during Caesarean section. 
This procedure is reported to be associated with intractable haemorrhage and postoperative morbidity by some authors while other 
authors advocate its safety. 
- Caesarean myomectomy is safe to perform in selected patients and results in no significant post-operative morbidity. The procedure can 
help younger patients avoid hysterectomy.
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The incidence of myoma associated with pregnancy is reported at 0.3–5%, with a majority of myomas not requiring 
surgical intervention during pregnancy or 
delivery.1–4 Myomectomy at the time of a Caesarean 
section has traditionally been discouraged due to 
fears of intractable haemorrhage and increased 
postoperative morbidity. However, a number of 
authors have recently shown that myomectomy 
at Caesarean does not increase the risk of 
haemorrhage.2,10–21
We present a series of 8 cases where 
myomectomy was performed during Caesarean 
section for large lower segment fibroids ranging 
in size from 4 to 12 cms. The antenatal course, 
perioperative management, and postoperative 
morbidity are discussed.
Methods
We performed a retrospective cohort study 
of 8 patients with myomas which resulted in 
pregnancy complications. All 8 patients underwent 
myomectomy at the time of Caesarean section 
at Sultan Qaboos University Hospital (SQUH) 
between January 1999 and December 2010. Ethical 
approval for the study was obtained from the 
University Medical Research and Ethics Committee 
(MREC #399). Patients’ medical records were 
perused for demographic data, parity, and antenatal 
course, type of Caesarean section, size and 
location of the fibroids, blood loss, postoperative 
morbidity, and neonatal outcome. All of the women 
in the study fulfilled the following five criteria: 1) 
documented fibroid during the index pregnancy 
by antenatal ultrasound or at surgery; 2) delivery 
by Caesarean; 3) no evidence of antenatal bleeding; 
4) no other procedure at Caesarean apart from 
myomectomy, and 5) no pre-existing coagulopathy. 
Informed consent was obtained from all patients 
preoperatively. Of the 8 patients studied, 7 had 
anterior lower segment fibroids and one had a 
posterior lower uterine fibroid which interfered 
with closure of the uterine incision. Adequate blood 
and blood products were arranged preoperatively.
Myomectomy was performed in the 
conventional fashion using an incision over the 
myoma, enucleating it, and obliterating the dead 
space in two to three layers using interrupted 1-0 
Vicryl sutures (Ethicon Inc., New Jersey, USA). 
Anterior lower segment myomas encroaching 
on the proposed incision line were excised prior 
to delivery of the baby while the others were 
removed after the baby had been delivered. The 
Caesarean incision was closed in 2 layers with 
1-0 Vicryl sutures. High dose oxytocin was used 
intraoperatively and postoperatively, and some 
patients required additional uterotonic agents. 
Blood loss was estimated from suction aspiration, 
and from weighing mops, swabs and drapes used 
during surgery. Prophylactic antibiotics were 
administered to all the patients. A review of 
literature was performed using PubMed, Medline, 
and Google.
Results
The average age of the women was 28.7 years. 
The age, parity, and associated risk factors of the 
patients; factors, size and location of the myomas; 
the operative findings and incisions used during 
surgery, and the complications and neonatal 
outcomes are summarised in Table 1. Of those in 
the study, 7 of the 8 patients had lower segment 
anterior wall fibroids at or close to the incision site, 
and one patient had a large posterior wall fibroid 
which projected through the uterine incision after 
delivery of the baby and needed removal to facilitate 
- The article highlights various new techniques that effectively control haemorrhage during Caesarean myomectomy, and has educational 
value for less experienced obstetricians.
Application to patient care 
- Caesarean myomectomy allows women to have a better obstetric outcome in future pregnancies, and to avoid hysterectomy.
- It relieves symptoms associated with fibroids and negates the need for later surgery or sonographic follow-ups for the fibroid after 
delivery.
- It is a safe procedure in selected patients when performed in tertiary care hospitals by experienced obstetricians with newer measures 
available to curtail haemorrhage.
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closure. In total, 4 were intramural fibroids (50%) 
and 4 were subserous. The size varied from 4–12 cm 
with 7 of them being larger than 5 cm in diameter. 
Regarding intra-operative blood loss, 1 patient lost 
900 ml, 5 patients lost 1–1.5 litres, 2 lost 1.5–2 L, 
and 1 patient with a 10 x 12 cm subserous fibroid 
lost 3.2 L. Stepwise devascularisation was needed 
to control atonic postpartum haemorrhage (PPH) 
in 1 patient. Preoperative placement of uterine 
balloon catheters was used in another patient with 
a large posterior wall fibroid. The balloon was 
inflated intra-operatively after delivery of the baby, 
effectively controlling the haemorrhage. None of 
the patients required hysterectomy. 
Neonatal outcome was good in all the patients. 
The mean gestational age at delivery was 36.75 
weeks (range 33–38 weeks). The 5 minute Apgar 
score was 9–10 in all the newborns with birth 
weights ranging from 2160 grams (preterm 33 
weeks) to 3,000 grams.
Table 1: Demographic and clinical profile, operative findings and outcome of the patients who underwent Caesarean 
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Legend: G/P/A = gravida/para/abortion; CS = Caesarean section; GA =gestational age; LUS = lower uterine segment; HT = hypertension; PPROM 
= preterm premature rupture of membranes; SUMLI = subumbilical midline longitudinal incision; ROP = right occipito-posterior position; UT = 
uterus; LSCS = lower segment Caesarean section; PIH = pregnancy induced hypertension; PPH = postpartum haemorrhage; PRBC = packed red 
blood cells, FFP = fresh frozen plasma;  Apg = Apgar score at 1 and 5 minutes
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Discussion
Uterine myomas are found in approximately 
0.3–5% of pregnant women, with the increasing 
incidence attributable to the fact that more and 
more women are delaying childbearing.1–4 One in 
ten of these women will have complications during 
pregnancy that are related to the myoma. A great 
majority of myomas associated with pregnancy 
remain asymptomatic and do not require treatment, 
with about 22–32% showing increased growth.5 
Larger fibroids (>5cm) are more likely to grow 
during pregnancy and can cause miscarriages, 
obstructed labour, malpresentations, pressure 
symptoms, pain due to red degeneration, preterm 
labour, preterm premature rupture of membranes, 
Table 2: A comparison of various studies on Cesarean myomectomy
Authors Roman11 Kwon15 Kaymak2 Ehigiegba16 Ortac10 Ahikari17 Omar19 Machado 
LSM
Year 2004 2003 2004 2001 1999 2006 1999 2011
No. and type of 
cases
368 88 120 25 22 14 2 8
111 CM 257 CS NA 40 CM 80 CS NA NA NA NA NA
Maternal Age 37 35 32.5±4.4 31.9±4.5 30.8±3.1 30.8±3.8 NA 25–35 yrs NA 28.75
Parity
 Para 0 NA NA 84.1% 0.8±1.2 1.1±1.1 13 NA 11 2 2
 Para 1-4 NA NA 16.9% NA NA 12 NA 3 0 6






38±1.19 37.7±2.5 37.6±1.4 36.9 (29–42) NA NA NA 36.75 
(33–38)
No. of Fibroids
 Single 91 67% 75% 10 NA 12 2 7
 Multiple 20 33% 25% 15 NA 2 0 1
Location
 Lower US NA 50% 11 (27.5%) NA NA 6 2 7
 Upper US NA 50% 22 (55%) NA NA 5 - 1
 Both NA - 7 (17.5%) NA NA 2 - -














 5-10 cms 4–5cm, 14 (35%) 2 7 - 6
 >10 cms ≥6cm, 24 (60%) - 2 2 1
Average Operating time
 LSCS - 51 (20–07) NA - 44.4±6.7 - - 35±3.28
NA
1,500 ml
 CM 55 (25–
161)








 Blood loss 12.6% 12.8% 731.5 ml 12.5% 11.3% 876 ±312 ml 324.2 ml 472 ml NA 1,500 ml











0.9% 1.2% 1 relap. 
for 
bleeding
4 (10%)  5 (6.3%) 5 NA 1 NA 4
 Fever 4.5% 4.7% 12 
(13.6%)
3 (7.5%) 8 (10%) 2 (8%) NA NA NA 0
 Anaemia NA NA NA NA NA 60% NA NA NA 2
Hysterectomy - - - - - - - - - -
Postop Hospital 
stay in days 
(range)





Legend: GA = gestational age; US =uterine segment; CM = Caesarean myomectomy; CS = Caesarean section; LSCS = lower segment Caesarean 
section; NA = not available or not specified; relap = relaparotomy
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retained placenta, postpartum haemorrhage and 
uterine torsion.5–7 Katz et al. found that 10–30% of 
women with myomas associated with pregnancy 
had complications as listed above.7 Caesarean 
section rates in women with myomas are higher, 
up to 73%, mainly due to obstructed labour and 
malpresentations.3
Preservation of the uterus without loss of its 
function and compromising the mother’s ability to 
bear more children is definitely a greater surgical 
achievement than a hysterectomy; hence, Caesarean 
myomectomy must be considered by experienced 
obstetricians wherever feasible. The orthodox 
view of one of the pioneers of myomectomy in 
non-pregnant women, Bonney, is reflected in his 
writings: “It is tempting for the adventurous and 
sympathetic surgeon to condense the operation of 
lower segment Caesarean section and myomectomy 
into one undertaking and save his patient the ordeal 
of a second admission to hospital. This kindly but 
misguided policy we heartily deprecate.” However, 
his pupils, Hawkins and Stallworthy, did advocate 
Caesarean myomectomy in selected cases, as in the 
incidence of anterior lower segment myomas on the 
proposed incision line.8 
Exacoustos and Rosetti reported that in their 
series of 9 cases of Caesarean myomectomy, 
three were complicated by severe haemorrhage 
necessitating hysterectomy; hence, they 
recommended caution while making the decision 
to perform this procedure.9 Some authors report 
a higher incidence of postpartum haemorrhage 
and puerperal sepsis if the fibroid is not removed 
at Caesarean section.3,4 In addition, the uterus in 
the immediate postpartum phase is better adapted 
physiologically to control haemorrhage than at any 
other stage in a woman’s life; hence, it seems logical 
to perform Caesarean myomectomy.
The management of fibroids encountered at 
Caesarean section remains a therapeutic dilemma. 
Myomectomy during Caesarean section has 
traditionally been discouraged due to the risk of 
uncontrollable haemorrhage, unless the myoma 
is pedunculated.11 Recent studies have described 
techniques to minimise blood loss at Caesarean 
myomectomy including uterine tourniquet, bilateral 
uterine artery ligation, and electrocautery.10,12,13 In 
our series, stepwise devascularisation was required 
to control atonic PPH in one patient; in another 
patient uterine artery balloon catheters were placed 
preoperatively. Several authors have now shown 
that in selected patients and in experienced hands, 
myomectomy at the time of caesarean section is a 
safe and effective procedure.2,10–21
The experience of different authors who have 
performed Caesarean myomectomies is presented 
in Table 2, including the present series. Roman et 
al. compared the outcomes of 111 patients who 
had had myomectomy at Caesarean with 257 
patients who had undergone Caesarean alone. No 
significant difference was found in the incidence of 
intra- or postoperative complications between the 2 
groups;11 however, accurate conclusions cannot be 
drawn from that study as only 22.7% of the patients 
had fibroids greater than 6 cm in diameter (median 
3.5 cm). 
Kaymak et al. compared 40 patients who 
underwent myomectomy at Caesarean section 
with 80 patients with myomas who underwent 
Caesarean section alone. The mean size of the 
fibroids removed was 8.1 cms compared to 5.7 cms 
in the controls. The authors found no significant 
difference in the incidence of haemorrhage (12.5% 
in the Caesarean myomectomy group versus 11.3% 
in the controls), postoperative fever, or frequency 
of blood transfusions between the 2 groups, and 
concluded that myomectomy during Caesarean 
section is not always a hazardous procedure and 
can be performed by experienced obstetricians 
without any complications.2
Ortac et al. reported 22 myomectomies during 
Caesarean for large fibroids (>5 cm) and advocate 
it to minimise postoperative sepsis.10 In another 
study by Burton et al., of the reported 13 cases of 
myomectomy at Caesarean section, only 1 case had 
intra-operative haemorrhage and they concluded it 
to be safe in selected patients.14
A large retrospective case-control study by 
Li Hui et al. assessed the effectiveness, safety, 
complications, and outcomes of myomectomy 
during Caesarean section in Chinese women 
with fibroids antedating pregnancy.20 The study 
group of 1,242 pregnant women with fibroids who 
underwent myomectomy during Caesarean section 
was compared with 3 control groups: 200 pregnant 
women without fibroids (Group A), 145 pregnant 
women with fibroids who underwent caesarean 
alone (Group B), and 51 pregnant women who 
underwent Caesarean hysterectomy (Group C). 
No significant differences were noted between 
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the groups in the mean haemoglobin change, the 
frequency of haemorrhage, postoperative fever, 
or the length of hospital stay. These findings 
corroborate the fact that myomectomy during 
Caesarean section is a safe, effective procedure not 
associated with significant complications.
Further strengthening the increasing trend 
towards Caesarean myomectomy is yet another 
case series by Hassiakos et al.21 They compared 
47 pregnant women with fibroids who underwent 
Caesarean myomectomy with 94 pregnant women 
with fibroids who had Caesarean section alone. 
Myomectomy added a mean operating time of 15 
minutes to the Caesarean section. No patient had 
a hysterectomy, postpartum complications, or 
blood transfusion. The length of hospital stay was 
comparable in both groups; hence, these authors 
also generally recommended performing the 
procedure. Yuddandi reported removal of a 33.3 × 
28.8 × 15.6 cm fibroid at Caesarean with an intra-
operative blood loss of 1,860 ml, necessitating blood 
transfusion.22 Leanza et al. and Igwegbe et al. have 
also reported large myomas removed at Caesarean 
section.23–24
In our series of 8 patients, 5 lost less than 1.5 L 
of blood and there was no significant postoperative 
morbidity. The patient with a blood loss of 3,200 
ml had the largest myoma in this series (10 x 12 
cm) which showed evidence of degeneration and 
also had atonicity of the uterus necessitating a 
higher dose of oxytocin, carboprost, and a blood 
transfusion. Since the fibroid was on the right 
anterior lower segment, a low vertical incision was 
used. The large size of the fibroid and atonic uterus 
led to the increased haemorrhage. There were no 
postoperative complications. 
Despite the majority of the patients having large 
myomas and 50% being intramurally located, no 
hysterectomy was required in any patient. Stepwise 
devascularisation was necessary in one case. The 
size of the fibroids was confirmed by the pathology 
reports, and changes like haemorrhage, infarction, 
calcification, and hyaline degeneration were seen in 
4 fibroids. Myomectomy added 15 minutes to the 
operating time and 1 day to the hospital stay but 
there was no significant postoperative complication. 
None of the patients had postoperative sepsis.
The limitations of this study are the small sample 
size and the retrospective nature of the study.
Conclusion
In conclusion, patient selection is crucial in 
Caesarean myomectomy. Large fundal intramural 
fibroids should be intuitively avoided. Intramural 
myomectomy should be performed with caution. 
Fibroids obstructing the lower uterine segment 
or accessible subserosal or pedunculated fibroids 
in symptomatic patients can be safely removed by 
experienced surgeons. The message is that what was 
once considered taboo should now be reconsidered. 
Measures to minimise blood loss, like 
preoperative placement of uterine artery, balloon 
catheters, uterotonic drugs, uterine artery ligation, 
uterine tourniquets, stepwise devascularisation, 
and post-Caesarean uterine artery embolisation 
would optimise outcomes and significantly 
decrease the chance of hysterectomy. The time is 
right to recommend Caesarean myomectomy in 
selected patients in well-equipped tertiary settings, 
which could also have a positive bearing on future 
reproductive outcomes.
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